These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25327099)

  • 1. Liraglutide-induced acute pancreatitis.
    Jeyaraj S; Shetty AS; Kumar CR; Nanditha A; Krishnamoorthy S; Raghavan A; Raghavan K; Ramachandran A
    J Assoc Physicians India; 2014 Jan; 62(1):64-6. PubMed ID: 25327099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute pancreatitis associated with liraglutide.
    Lee PH; Stockton MD; Franks AS
    Ann Pharmacother; 2011 Apr; 45(4):e22. PubMed ID: 21487080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liraglutide: a human GLP-1 analogue for the treatment of diabetes mellitus type 2].
    Jahn E; Sausele T
    Med Monatsschr Pharm; 2009 Nov; 32(11):402-7. PubMed ID: 19947303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liraglutide-associated acute pancreatitis.
    Knezevich E; Crnic T; Kershaw S; Drincic A
    Am J Health Syst Pharm; 2012 Mar; 69(5):386-9. PubMed ID: 22345417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes--focus on pancreatitis and pancreas cancer.
    Chalmer T; Almdal TP; Vilsbøll T; Knop FK
    Expert Opin Drug Saf; 2015 Jan; 14(1):171-80. PubMed ID: 25363438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute pancreatitis in a patient treated with liraglutide].
    Artero A; Bourguet M; Lorente RI; Real JT
    Med Clin (Barc); 2013 Oct; 141(8):368-9. PubMed ID: 23507272
    [No Abstract]   [Full Text] [Related]  

  • 7. Exenatide and acute pancreatitis.
    Tripathy NR; Basha S; Jain R; Shetty S; Ramachandran A
    J Assoc Physicians India; 2008 Dec; 56():987-8. PubMed ID: 19322980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide (Victoza) for type 2 diabetes.
    Med Lett Drugs Ther; 2010 Apr; 52(1335):25-7. PubMed ID: 20360660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatitis: a potential complication of liraglutide?
    Franks AS; Lee PH; George CM
    Ann Pharmacother; 2012 Nov; 46(11):1547-53. PubMed ID: 23136352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late and severe acute necrotizing pancreatitis in a patient with liraglutide.
    Bourezane H; Kastler B; Kantelip JP
    Therapie; 2012; 67(6):539-43. PubMed ID: 23249582
    [No Abstract]   [Full Text] [Related]  

  • 11. Next-generation GLP-1 therapy: an introduction to liraglutide.
    Repas T
    Postgrad Med; 2011 Sep; 123(5):239-47. PubMed ID: 21904107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novo Nordisk replies to BMJ investigation on incretins and pancreatic damage.
    Moses A
    BMJ; 2013 Jul; 347():f4386. PubMed ID: 23842435
    [No Abstract]   [Full Text] [Related]  

  • 13. GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide.
    Hegedüs L; Moses AC; Zdravkovic M; Le Thi T; Daniels GH
    J Clin Endocrinol Metab; 2011 Mar; 96(3):853-60. PubMed ID: 21209033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus.
    Montanya E; Sesti G
    Clin Ther; 2009 Nov; 31(11):2472-88. PubMed ID: 20109994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatitis during treatment with liraglutide.
    Famularo G; Gasbarrone L; Minisola G
    JOP; 2012 Sep; 13(5):540-1. PubMed ID: 22964963
    [No Abstract]   [Full Text] [Related]  

  • 16. Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes.
    Ryan GJ; Hardy Y
    J Clin Pharm Ther; 2011 Jun; 36(3):260-74. PubMed ID: 21545609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer.
    Alves C; Batel-Marques F; Macedo AF
    Diabetes Res Clin Pract; 2012 Nov; 98(2):271-84. PubMed ID: 23010561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
    Deacon CF; Mannucci E; Ahrén B
    Diabetes Obes Metab; 2012 Aug; 14(8):762-7. PubMed ID: 22471248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide for type 2 diabetes?
    Drug Ther Bull; 2010 May; 48(5):50-3. PubMed ID: 20447980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide - overview of the preclinical and clinical data and its role in the treatment of type 2 diabetes.
    Davies MJ; Kela R; Khunti K
    Diabetes Obes Metab; 2011 Mar; 13(3):207-20. PubMed ID: 21205109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.